All the methods for measuring PD‐1/PD‐L1 expression on tumor cells and/or tumor-infiltrating lymphocytes (TILs) in primary cancer tissues (on the cell membrane, cytoplasm, or both) were accepted. This evidence concerns the gene CD274 and neoplasm.